These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19574424)
21. Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Iglesias BV; Centeno G; Pascuccelli H; Ward F; Peters MG; Filmus J; Puricelli L; de Kier Joffé EB Histol Histopathol; 2008 Nov; 23(11):1333-40. PubMed ID: 18785116 [TBL] [Abstract][Full Text] [Related]
22. Glypican-3 expression is silenced in human breast cancer. Xiang YY; Ladeda V; Filmus J Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870 [TBL] [Abstract][Full Text] [Related]
23. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Davoodi J; Kelly J; Gendron NH; MacKenzie AE Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790 [TBL] [Abstract][Full Text] [Related]
24. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660 [TBL] [Abstract][Full Text] [Related]
25. A patient with Simpson-Golabi-Behmel syndrome, biliary cirrhosis and successful liver transplantation. Jedraszak G; Girard M; Mellos A; Djeddi DD; Chardot C; Vanrenterghem A; Moizard MP; Gondry J; Sevestre H; Mathieu-Dramard M; Lacaille F; Demeer B Am J Med Genet A; 2014 Mar; 164A(3):774-7. PubMed ID: 24357529 [TBL] [Abstract][Full Text] [Related]
26. Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehog. Capurro MI; Li F; Filmus J EMBO Rep; 2009 Aug; 10(8):901-7. PubMed ID: 19590577 [TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of a novel intragenic deletion in GPC3 in three cousins with Simpson-Golabi-Behmel syndrome. Schmidt J; Hollstein R; Kaiser FJ; Gillessen-Kaesbach G Am J Med Genet A; 2017 May; 173(5):1400-1405. PubMed ID: 28371070 [TBL] [Abstract][Full Text] [Related]
28. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Capurro MI; Xu P; Shi W; Li F; Jia A; Filmus J Dev Cell; 2008 May; 14(5):700-11. PubMed ID: 18477453 [TBL] [Abstract][Full Text] [Related]
29. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Grozdanov PN; Yovchev MI; Dabeva MD Lab Invest; 2006 Dec; 86(12):1272-84. PubMed ID: 17117158 [TBL] [Abstract][Full Text] [Related]
30. Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature. Vuillaume ML; Moizard MP; Rossignol S; Cottereau E; Vonwill S; Alessandri JL; Busa T; Colin E; Gérard M; Giuliano F; Lambert L; Lefevre M; Kotecha U; Nampoothiri S; Netchine I; Raynaud M; Brioude F; Toutain A Hum Mutat; 2018 Jun; 39(6):790-805. PubMed ID: 29637653 [TBL] [Abstract][Full Text] [Related]
31. Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells. Gao W; Kim H; Ho M PLoS One; 2015; 10(9):e0137664. PubMed ID: 26332121 [TBL] [Abstract][Full Text] [Related]
32. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Lin H; Huber R; Schlessinger D; Morin PJ Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line. Ruan J; Liu F; Chen X; Zhao P; Su N; Xie G; Chen J; Zheng D; Luo R Int J Mol Med; 2011 Oct; 28(4):497-503. PubMed ID: 21617840 [TBL] [Abstract][Full Text] [Related]
34. Glypican 3 and glypican 4 are juxtaposed in Xq26.1. Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407 [TBL] [Abstract][Full Text] [Related]
35. Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway. Cheng W; Tseng CJ; Lin TT; Cheng I; Pan HW; Hsu HC; Lee YM Carcinogenesis; 2008 Jul; 29(7):1319-26. PubMed ID: 18413366 [TBL] [Abstract][Full Text] [Related]
36. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610 [TBL] [Abstract][Full Text] [Related]
38. A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice. Li N; Wei L; Liu X; Bai H; Ye Y; Li D; Li N; Baxa U; Wang Q; Lv L; Chen Y; Feng M; Lee B; Gao W; Ho M Hepatology; 2019 Oct; 70(4):1231-1245. PubMed ID: 30963603 [TBL] [Abstract][Full Text] [Related]
39. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression. Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579 [TBL] [Abstract][Full Text] [Related]
40. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP. Miao HL; Pan ZJ; Lei CJ; Wen JY; Li MY; Liu ZK; Qiu ZD; Lin MZ; Chen NP; Chen M J Cell Biochem; 2013 Mar; 114(3):625-31. PubMed ID: 23060277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]